Management of venous thromboembolic diseases and the role of thrombophilia testing: Summary of NICE guidance

BMJ (Online)

Volumn 345, Issue 7864, 2012, Pages

  Chong, Lee Yee ^a   Fenu, Elisabetta ^a   Stansby, Gerard ^b   Hodgkinson, Sarah ^a  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; FUNCTIONAL STATUS; HUMAN; LEG VEIN; LIFE EXPECTANCY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 84863600745     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e3979     Document Type: Article

References (10)

1. National Institute for Health and Clinical Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. (Clinical guideline 144.) 2012. http://guidance.nice.org.uk/CG144.
2. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003;349:1227-35. (Pubitemid 37152032)
3. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83:416-20. (Pubitemid 30148355)
4. McRae S, Tran H, Schulman S, Ginsberg J, Kearon C. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 2006;368:371-8. (Pubitemid 44108120)
5. Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011;342:d813.
6. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, LE GG, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008;179:417-26.
7. Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005;3:2671-6. (Pubitemid 41819794)
8. Palareti G, Legnani C, Cosmi B, Valdre L, Lunghi B, Bernardi F, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003;108:313-8. (Pubitemid 36899022)
9. Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008;149:481-90.
10. National Institute for Health and Clinical Excellence. The guidelines manual 2009. www.nice.org.uk/guidelinesmanual.